Product Code: ETC13149449 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Newborn Screening Market was valued at USD 1.5 Billion in 2024 and is expected to reach USD 2.2 Billion by 2031, growing at a compound annual growth rate of 7.90% during the forecast period (2025-2031).
The Global Newborn Screening Market is experiencing significant growth due to increasing awareness about early disease detection in infants. This market involves the testing of newborns for a variety of genetic, metabolic, and congenital disorders shortly after birth. The key factors driving market growth include technological advancements in screening techniques, government initiatives to expand newborn screening programs, and a growing focus on personalized medicine. Additionally, rising birth rates and the increasing prevalence of genetic disorders worldwide are fueling the demand for newborn screening services. The market is characterized by the presence of key players such as PerkinElmer Inc., Bio-Rad Laboratories, and Natus Medical Incorporated, who are constantly innovating to develop efficient and accurate screening solutions for early disease detection in newborns.
The Global Newborn Screening Market is witnessing significant growth due to increasing awareness about early disease detection in infants and technological advancements in screening techniques. The market is driven by the rising prevalence of genetic disorders and congenital diseases among newborns, driving the demand for screening tests. Additionally, government initiatives to promote newborn screening programs in developing countries are further fueling market growth. Opportunities in the market include the development of point-of-care testing solutions, expansion of screening programs to cover a wider range of disorders, and integration of advanced technologies like next-generation sequencing for more accurate and comprehensive screening. Overall, the Global Newborn Screening Market is poised for continued expansion, with key players focusing on innovation and strategic collaborations to capitalize on these trends.
The Global Newborn Screening Market faces several challenges, including lack of awareness and infrastructure in developing regions, high cost associated with advanced screening technologies, and varying regulations and guidelines across different countries. Limited access to screening programs in rural areas and the need for skilled healthcare professionals to conduct tests also pose significant challenges. Additionally, the ethical considerations surrounding screening for certain genetic conditions and the potential for false-positive results leading to unnecessary parental anxiety and follow-up testing are key challenges in the newborn screening market. Overcoming these obstacles will require collaboration between governments, healthcare providers, and industry stakeholders to improve access, affordability, and standardization of newborn screening practices globally.
The Global Newborn Screening Market is primarily driven by increasing prevalence of newborn diseases and genetic disorders, growing awareness about early disease detection, and government initiatives promoting newborn screening programs. Technological advancements in screening techniques, such as the adoption of next-generation sequencing and digital microfluidics, are also contributing to market growth by enhancing the accuracy and effectiveness of screening tests. Additionally, rising healthcare expenditure, improving healthcare infrastructure in developing countries, and the expanding newborn population are fueling the demand for newborn screening services. The shift towards personalized medicine and the development of innovative screening technologies are expected to further drive market growth in the coming years.
Government policies related to the Global Newborn Screening Market focus on ensuring the universal implementation of newborn screening programs to detect and prevent inherited disorders and diseases in infants. These policies emphasize the importance of early diagnosis and treatment to improve health outcomes and reduce healthcare costs in the long term. Governments across the world are increasingly investing in expanding newborn screening programs, standardizing testing procedures, and ensuring access to screening services for all newborns. Additionally, regulatory bodies are working towards setting guidelines for quality assurance, data management, and ethical considerations to safeguard the rights and privacy of individuals undergoing screening. Overall, government policies aim to promote the growth and sustainability of the Global Newborn Screening Market while prioritizing the health and well-being of infants worldwide.
The Global Newborn Screening Market is expected to experience significant growth in the coming years, driven by factors such as increasing awareness about early disease detection in newborns, technological advancements in screening tests, and government initiatives to expand newborn screening programs. The market is anticipated to witness a surge in demand for newborn screening tests to diagnose various genetic, metabolic, and congenital disorders at an early stage, enabling timely interventions and improved health outcomes. Additionally, the rising prevalence of genetic disorders and the growing emphasis on preventive healthcare are likely to further propel market growth. However, challenges such as high costs associated with screening tests and limited healthcare infrastructure in developing regions may hinder the market`s full potential. Overall, the Global Newborn Screening Market is poised for expansion, with opportunities for innovation and improved accessibility to screening services.
In the global newborn screening market, North America holds a significant share due to widespread adoption of advanced technologies and well-established healthcare infrastructure. Asia Pacific is poised for significant growth with rising awareness about early disease detection and increasing government initiatives to improve healthcare access. Europe is also a key market driven by favorable reimbursement policies and increasing focus on preventive healthcare. The Middle East and Africa region is experiencing growth supported by expanding healthcare facilities and a growing emphasis on newborn health. Latin America is witnessing steady market growth due to improving healthcare infrastructure and increasing investments in newborn screening programs. Overall, the global newborn screening market is expected to continue expanding across all regions driven by advancements in technology and growing awareness about the benefits of early disease detection in infants.
Global Newborn Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Newborn Screening Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Newborn Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Global Newborn Screening Market - Industry Life Cycle |
3.4 Global Newborn Screening Market - Porter's Five Forces |
3.5 Global Newborn Screening Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Newborn Screening Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Newborn Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.8 Global Newborn Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Newborn Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Newborn Screening Market Trends |
6 Global Newborn Screening Market, 2021 - 2031 |
6.1 Global Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Newborn Screening Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.3 Global Newborn Screening Market, Revenues & Volume, By Assay Kits, 2021 - 2031 |
6.2 Global Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Newborn Screening Market, Revenues & Volume, By Dry Blood Spot Test, 2021 - 2031 |
6.2.3 Global Newborn Screening Market, Revenues & Volume, By Hearing Screen Test, 2021 - 2031 |
6.2.4 Global Newborn Screening Market, Revenues & Volume, By Critical Congenital Heart Disease (CCHD) Test, 2021 - 2031 |
6.2.5 Global Newborn Screening Market, Revenues & Volume, By X-ray or CT Scan, 2021 - 2031 |
6.2.6 Global Newborn Screening Market, Revenues & Volume, By Electrocardiogram (ECG) Test, 2021 - 2031 |
6.2.7 Global Newborn Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Newborn Screening Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Newborn Screening Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.4 Global Newborn Screening Market, Revenues & Volume, By Maternity & Specialty Clinics, 2021 - 2031 |
6.3.5 Global Newborn Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Newborn Screening Market, Overview & Analysis |
7.1 North America Newborn Screening Market Revenues & Volume, 2021 - 2031 |
7.2 North America Newborn Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.5 North America Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Newborn Screening Market, Overview & Analysis |
8.1 Latin America (LATAM) Newborn Screening Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Newborn Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
8.5 Latin America (LATAM) Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Newborn Screening Market, Overview & Analysis |
9.1 Asia Newborn Screening Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Newborn Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
9.5 Asia Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Newborn Screening Market, Overview & Analysis |
10.1 Africa Newborn Screening Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Newborn Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
10.5 Africa Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Newborn Screening Market, Overview & Analysis |
11.1 Europe Newborn Screening Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Newborn Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
11.5 Europe Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Newborn Screening Market, Overview & Analysis |
12.1 Middle East Newborn Screening Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Newborn Screening Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Newborn Screening Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Newborn Screening Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Newborn Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
12.5 Middle East Newborn Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Newborn Screening Market Key Performance Indicators |
14 Global Newborn Screening Market - Export/Import By Countries Assessment |
15 Global Newborn Screening Market - Opportunity Assessment |
15.1 Global Newborn Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Newborn Screening Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Newborn Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
15.4 Global Newborn Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Newborn Screening Market - Competitive Landscape |
16.1 Global Newborn Screening Market Revenue Share, By Companies, 2024 |
16.2 Global Newborn Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |